There are no written procedures for production and process controls designed to assure that the drug products have the identity, strength, quality, and purity they purport or are represented to possess.
Inspection Record
Orean Personal Care Ltd — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.
Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Written procedures are lacking which describe in sufficient detail the receipt, sampling and testing of components of drug products.
The responsibilities and procedures applicable to the quality contro] unit are not in writing and/or fully followed.
Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards, sampling plans, test procedures designed to assure that components of drug product, in-process materials, and drug products conform to appropriate standards of identity, strength, quality and purity.
There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
There wasa failure to handle and store components of drug product at all times in a manner to prevent contamination.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Neva Analytics, LLC2026-04-01 · US FDASimilar to finding 2 Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are…
- Huons Co., Ltd2025-11-21 · US FDASimilar to finding 7 There is a failure to thoroughly review any unexplained discrepancy or the failure of a batch or any of its components to meet any of its specifications…
- Baxalta US Inc.2025-11-26 · US FDASimilar to finding 3 Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or…
- Cipla Limited2019-09-27 · US FDASimilar to finding 3 Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or…
- Macau-Union Pharmaceutical Limited2025-12-17 · US FDASimilar to finding 3 Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or…
A record as of the US FDA document published on 2026-11-12. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.